GHIT Fund to host panel discussion to examine recent successes, setbacks in global health

Engaging new partners to save lives

The Global Health Innovative Technology Fund (GHIT Fund), along with the New York Academy of Sciences and Japan Society, will host a panel discussion - comprised of preeminent global health experts - to examine recent successes and setbacks in global health and what they see as the secret ingredient to moving a vaccine, cure or diagnostic across the finish line and into the field.

Panelists will provide their unique perspectives on:

  • How do these partnerships find success in the face of seemingly insurmountable challenges?
  • What have we learned from past successes that make the difference between a breakthrough diagnostic or treatment and a trip back to the drawing board?
  • Where are the opportunities for the next big solutions?
  • Who is missing from the table in the effort to push back against HIV, TB, malaria and neglected tropical diseases?
  • Why should those outside the global health and NGO worlds join this effort?

The discussion will include an opportunity for questions from attendees. A networking reception will follow the panel.

November 12, 2013



  • Peter Piot, M.D., Ph.D.
    Director, London School of Hygiene & Tropical Medicine; Former Executive Director of UNAIDS; GHIT Fund Board Member
  • Ann M. Veneman, J.D.
    Former Executive Director of UNICEF; Former Secretary of Agriculture; GHIT Fund Board Member
  • Mel Spigelman, M.D.
    President and CEO, Global Alliance for TB Drug Development (TB Alliance); GHIT Fund Grantee
  • Kiyoshi Kurokawa, M.D.
    Chair of the Board of GHIT Fund; Academic Fellow, National Graduate Institute for Policy Studies; Chairman, Health and Global Policy Institute


  • Ko-Yung Tung, J.D.
    Senior Counselor, Morrison & Foerster; GHIT Fund Board Advisor


Japan Society
333 East 47th Street
New York, NY 10017


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Modeling COVID-19 hospital capacity